Segment of glycosylation-deficient HGFalpha-chain

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Hormone or other secreted growth regulatory factor,...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S350000, C435S440000

Reexamination Certificate

active

07807177

ABSTRACT:
The present invention provides a segment of glycosylation-deficient HGF having mutation(s) introduced into an amino acid sequence so as to prevent glycosylation at at least one glycosylation site of a hepatocyte growth factor (HGF), and a method of producing the same. The segment of glycosylation-deficient HGF of the present invention has the same activity as that of a segment of glycosylated HGF, therefore, it is useful as an alternate for a segment of glycosylated HGF.

REFERENCES:
patent: 2003/0162736 (2003-08-01), Nakamura et al.
Date et al. FEBS Letters 420: 1-6, Jan. 1998.
Shimizu et al. Biochemical and Biophysical Research Communications 189(3): 1329-1335, Dec. 30, 1992.
Glass and Heinz, Chapter 6, Artificial DNA Methods and Applications, Editors Khudyakov and Fields, CRC Press, London, (2003).
Mizuno et al., The Journal of Biological Chemistry, 269(2): 1131-1136, Jan. 14, 1994.
Bruce-Chwatt LJ. British Medical Journal, 285: 674-676. (1982).
Fukuta et al. Biochem J. 388:555-562 (2005).
N. Shimizu et al., “Hepatocyte Growth Factor is Linked by O-Glycosylated Oligosaccharide on the α Chain”, Biochemical and Biophysical Research Communications, vol. 189, No. 3, pp. 1329-1335, Dec. 30, 1992.
S. J. Stahl et al., “Functional and Biophysical Characterization of Recombinant Human Hepatocyte Growth Factor Isoforms Produced inEscherichia coli”, Biochem. J., vol. 326, pp. 763-772, 1997.
K. Kuba et al., “Kringle 1-4 of Hepatocyte Growth Factor Inhibits Proliferation and Migration of Human Microvascular Endothelial Cells”, Biochemical and Biophysical Research Communications, vol. 279, No. 3, pp. 846-852, Dec. 29, 2000.
R. Hofmann et al., “Scatter factor is a glycoprotein but glycosylation is not required for its activity”, Biochimica et Biophysica Acta, vol. 1120, No. 3, pp. 343-350, 1992.
N. Shimizu et al., “Hepatocyte Growth Factor is Linked by O-Glycosylated Oligosaccharide on the α Chain”, Biochemical and Biophysical Research Communications, vol. 189, No. 3, pp. 1329-1335, Dec. 30, 1992.
K. Date et al., “HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor”, FEBS Letters, vol. 420, No. 1, pp. 1-6, 1997.
K. Fukuta et al., “Multiple Biological Responses are Induced by Glycosylation-Deficient Hepatocyte Growth Factor”, Biochemical Journal, Feb. 4, 2005.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Segment of glycosylation-deficient HGFalpha-chain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Segment of glycosylation-deficient HGFalpha-chain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Segment of glycosylation-deficient HGFalpha-chain will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4185731

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.